Enabling stem cell therapies through synthetic stem cell-niche engineering

Journal of Clinical Investigation

Volumn 120, Issue 1, 2010, Pages 60-70

  Peerani, Raheem ^a   Zandstra, Peter W ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c HEART AND STROKE FOUNDATION OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANTIGEN; BETA1 INTEGRIN; BONE MORPHOGENETIC PROTEIN; CALCIUM ION; COLLAGEN TYPE 1; CYTOKINE; DICKKOPF 1 PROTEIN; FIBROBLAST GROWTH FACTOR; LIPOCORTIN 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NOTCH RECEPTOR; OSTEOPONTIN; OXYGEN; PARATHYROID HORMONE; PLERIXAFOR; REACTIVE OXYGEN METABOLITE; SONIC HEDGEHOG PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VERY LATE ANTIGEN 4; WNT PROTEIN;

AUTOCRINE EFFECT; BLOOD FLOW; CELL CONTACT; CELL FATE; CELL INTERACTION; CYTOKINE PRODUCTION; ENGINEERING; EXTRACELLULAR MATRIX; HYPOXIA; MICROARRAY ANALYSIS; MICROENVIRONMENT; MICROFLUIDIC ANALYSIS; NEUROTRANSMISSION; NONHUMAN; PARACRINE SIGNALING; PH; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REGENERATIVE MEDICINE; REVIEW; SHEAR STRESS; STEM CELL TRANSPLANTATION; ANIMAL; BIOENGINEERING; CELL COMMUNICATION; HEMATOPOIETIC STEM CELL; HUMAN; PHYSIOLOGY;

ANIMALS; BIOENGINEERING; CELL COMMUNICATION; CYTOKINES; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; OXYGEN; STEM CELL TRANSPLANTATION;

EID: 74949142277     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI41158     Document Type: Review

References (131)

1. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc. 2009;84(10):876-892.
2. Trounson A. New perspectives in human stem cell therapeutic research. BMC Med. 2009;7:29.
3. Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells. Science. 2009;324(5935):1673-1677.
4. Lane SW, Scadden DT, Gilliland DG. The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood. 2009;114(6):1150-1157.
5. Jones DL, Wagers AJ. No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol. 2008;9(1):11-21.
6. Scadden DT. The stem-cell niche as an entity of action. Nature. 2006;441(7097):1075-1079.
7. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol. 2008;8(4):290-301.
8. Carlson ME, Hsu M, Conboy IM. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature. 2008;454(7203):528-532.
9. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433(7027):760-764.
10. Spiegel A, Kalinkovich A, Shivtiel S, Kollet O, Lapidot T. Stem cell regulation via dynamic interactions of the nervous and immune systems with the microenvironment. Cell Stem Cell. 2008;3(5):484-492.
11. Katayama Y, et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell. 2006;124(2):407-421.
12. Johnston LA. Competitive interactions between cells: death, growth, and geography. Science. 2009;324(5935):1679-1682.
13. Yoder MC, Hiatt K, Dutt P, Mukherjee P, Bodine DM, Orlic D. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. Immunity. 1997;7(3):335-344.
14. Zovein AC, et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell. 2008;3(6):625-636.
15. Samokhvalov IM, Samokhvalova NI, Nishikawa S. Cell tracing shows the contribution of the yolk sac to adult haematopoiesis. Nature. 2007;446(7139):1056-1061.
16. Rhodes KE, et al. The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell. 2008;2(3):252-263.
17. Houssaint E. Differentiation of the mouse hepatic primordium. II. Extrinsic origin of the haemopoietic cell line. Cell Differ. 1981;10(5):243-252.
18. Cumano A, Godin I. Ontogeny of the hematopoietic system. Annu Rev Immunol. 2007;25:745-785.
19. Bowie MB, et al. Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties. Proc Natl Acad Sci U S A. 2007;104(14):5878-5882.
20. Wu JY, Scadden DT, Kronenberg HM. Role of the osteoblast lineage in the bone marrow hematopoietic niches. J Bone Miner Res. 2009;24(5):759-764.
21. Garrett RW, Emerson SG. The role of parathyroid hormone and insulin-like growth factors in hematopoietic niches: physiology and pharmacology. Mol Cell Endocrinol. 2008;288(1-2):6-10.
22. Zhang J, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003;425(6960):836-841.
23. Calvi LM, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425(6960):841-846.
24. Garrett RW, Emerson SG. Bone and blood vessels: the hard and the soft of hematopoietic stem cell niches. Cell Stem Cell. 2009;4(6):503-506.
25. Kiel MJ, Morrison SJ. Maintaining hematopoietic stem cells in the vascular niche. Immunity. 2006;25(6):862-864.
26. Xie Y, et al. Detection of functional haematopoietic stem cell niche using real-time imaging. Nature. 2009;457(7225):97-101.
27. Lo Celso C, et al. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature. 2009;457(7225):92-96.
28. Hooper AT, et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell. 2009;4(3):263-274.
29. Kirouac DC, Madlambayan GJ, Yu M, Sykes EA, Ito C, Zandstra PW. Cell-cell interaction networks regulate blood stem and progenitor cell fate. Mol Syst Biol. 2009;5:293.
30. Peerani R, et al. Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J. 2007;26(22):4744-4755.
31. Nelson CM, Chen CS. Cell-cell signaling by direct contact increases cell proliferation via a PI3K-dependent signal. FEBS Lett. 2002;514(2-3):238-242.
32. Flaim CJ, Teng D, Chien S, Bhatia SN. Combinatorial signaling microenvironments for studying stem cell fate. Stem Cells Dev. 2008;17(1):29-39.
33. Soen Y, Mori A, Palmer TD, Brown PO. Exploring the regulation of human neural precursor cell differentiation using arrays of signaling microenvironments. Mol Syst Biol. 2006;2:37.
34. Song H, et al. Regenerative medicine special feature: interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue [published online ahead of print October 21, 2009]. Proc Natl Acad Sci U S A. doi:10.1073/pnas.0905729106.
35. Shin H, Zygourakis K, Farach-Carson MC, Yaszemski MJ, Mikos AG. Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials. 2004;25(5):895-906.
36. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol. 2001;19(11):1029-1034.
37. Yang XB, et al. Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. Tissue Eng. 2004;10(7-8):1037-1045.
38. Jervis EJ, Guarna MM, Doheny JG, Haynes CA, Kilburn DG. Dynamic localization and persistent stimulation of factor-dependent cells by a stem cell factor / cellulose binding domain fusion protein. Biotechnol Bioeng. 2005;91(3):314-324.
39. Alberti K, et al. Functional immobilization of signaling proteins enables control of stem cell fate. Nat Methods. 2008;5(7):645-650.
40. Fan VH, et al. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells. 2007;25(5):1241-1251.
41. Suzuki T, et al. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein. Stem Cells. 2006;24(11):2456-2465.
42. Kapur TA, Shoichet MS. Chemically-bound nerve growth factor for neural tissue engineering applications. J Biomater Sci Polym Ed. 2003;14(4):383-394.
43. Mapili G, Lu Y, Chen S, Roy K. Laser-layered microfabrication of spatially patterned functionalized tissue-engineering scaffolds. J Biomed Mater Res B Appl Biomater. 2005;75(2):414-424.
44. Mayer M, Yang J, Gitlin I, Gracias DH, Whitesides GM. Micropatterned agarose gels for stamping arrays of proteins and gradients of proteins. Proteomics. 2004;4(8):2366-2376.
45. Jiang X, Xu Q, Dertinger SK, Stroock AD, Fu TM, Whitesides GM. A general method for patterning gradients of biomolecules on surfaces using microfluidic networks. Anal Chem. 2005;77(8):2338-2347.
46. Nuttelman CR, Tripodi MC, Anseth KS. Dexamethasone-functionalized gels induce osteogenic differentiation of encapsulated hMSCs. J Biomed Mater Res A. 2006;76(1):183-195.
47. Kim S, Healy KE. Synthesis and characterization of injectable poly(N-isopropylacrylamide-co-acrylic acid) hydrogels with proteolytically degradable cross-links. Biomacromolecules. 2003;4(5):1214-1223.
48. Li Jeon N, Baskaran H, Dertinger SK, Whitesides GM, Van de Water L, Toner M. Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device. Nat Biotechnol. 2002;20(8):826-830.
49. Kim L, Vahey MD, Lee HY, Voldman J. Microfluidic arrays for logarithmically perfused embryonic stem cell culture. Lab Chip. 2006;6(3):394-406.
50. Chung BG, et al. Human neural stem cell growth and differentiation in a gradient-generating microfluidic device. Lab Chip. 2005;5(4):401-406.
51. Park TH, Shuler ML. Integration of cell culture and microfabrication technology. Biotechnol Prog. 2003;19(2):243-253.
52. Li YJ, Chung EH, Rodriguez RT, Firpo MT, Healy KE. Hydrogels as artificial matrices for human embryonic stem cell self-renewal. J Biomed Mater Res A. 2006;79(1):1-5.
53. Biggs MJ, Richards RG, Gadegaard N, Wilkinson CD, Oreffo RO, Dalby MJ. The use of nanoscale topography to modulate the dynamics of adhesion formation in primary osteoblasts and ERK/MAPK signalling in STRO-1+ enriched skeletal stem cells. Biomaterials. 2009;30(28):5094-5103.
54. Nelson CM, Jean RP, Tan JL, Liu WF, Sniadecki NJ, Spector AA, Chen CS. Emergent patterns of growth controlled by multicellular form and mechanics. Proc Natl Acad Sci U S A. 2005;102(33):11594-11599.
55. Anderson DG, Levenberg S, Langer R. Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol. 2004;22(7):863-866.
56. Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak-Novakovic G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A. 2007;104(27):11298-11303.
57. Oswald J, et al. Gene-expression profiling of CD34+ hematopoietic cells expanded in a collagen I matrix. Stem Cells. 2006;24(3):494-500.
58. Chua KN, Chai C, Lee PC, Ramakrishna S, Leong KW, Mao HQ. Functional nanofiber scaffolds with different spacers modulate adhesion and expansion of cryopreserved umbilical cord blood hematopoietic stem/progenitor cells. Exp Hematol. 2007;35(5):771-781.
59. Flaim CJ, Chien S, Bhatia SN. An extracellular matrix microarray for probing cellular differentiation. Nat Methods. 2005;2(2):119-125.
60. Taqvi S, Dixit L, Roy K. Biomaterial-based notch signaling for the differentiation of hematopoietic stem cells into T cells. J Biomed Mater Res A. 2006;79(3):689-697.
61. Awong G, Herer E, Surh CD, Dick JE, La Motte-Mohs RN, Zuniga-Pflucker JC. Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells. Blood. 2009;114(5):972-982.
62. Nagaoka M, et al. Design of the artificial acellular feeder layer for the efficient propagation of mouse embryonic stem cells. J Biol Chem. 2008;283(39):26468-26476.
63. Stevens MM, Mayer M, Anderson DG, Weibel DB, Whitesides GM, Langer R. Direct patterning of mammalian cells onto porous tissue engineering substrates using agarose stamps. Biomaterials. 2005;26(36):7636-7641.
64. Rosenthal A, Macdonald A, Voldman J. Cell patterning chip for controlling the stem cell microenvironment. Biomaterials. 2007;28(21):3208-3216.
65. Parekkadan B, et al. Cell-cell interaction modulates neuroectodermal specification of embryonic stem cells. Neurosci Lett. 2008;438(2):190-195.
66. Hui EE, Bhatia SN. Micromechanical control of cell-cell interactions. Proc Natl Acad Sci U S A. 2007;104(14):5722-5726.
67. Bhatia SN, Yarmush ML, Toner M. Controlling cell interactions by micropatterning in co-cultures: hepatocytes and 3T3 fibroblasts. J Biomed Mater Res. 1997;34(2):189-199.
68. Fukuda J, et al. Micropatterned cell co-cultures using layer-by-layer deposition of extracellular matrix components. Biomaterials. 2006; 27(8):1479-1486.
69. Jinno S, et al. Microfabricated multilayer parylene-C stencils for the generation of patterned dynamic cocultures. J Biomed Mater Res A. 2008;86(1):278-288.
70. Guilak F, Cohen DM, Estes BT, Gimble JM, Liedtke W, Chen CS. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell. 2009;5(1):17-26.
71. Takeda H, Komori K, Nishikimi N, Nimura Y, Sokabe M, Naruse K. Bi-phasic activation of eNOS in response to uni-axial cyclic stretch is mediated by differential mechanisms in BAECs. Life Sci. 2006;79(3):233-239.
72. Tan JL, Tien J, Pirone DM, Gray DS, Bhadriraju K, Chen CS. Cells lying on a bed of microneedles: an approach to isolate mechanical force. Proc Natl Acad Sci U S A. 2003;100(4):1484-1489.
73. Adamo L, et al. Biomechanical forces promote embryonic haematopoiesis. Nature. 2009; 459(7250):1131-1135.
74. North TE, et al. Hematopoietic stem cell development is dependent on blood flow. Cell. 2009; 137(4):736-748.
75. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126(4):677-689.
76. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell. 2004;6(4):483-495.
77. Tschumperlin DJ, et al. Mechanotransduction through growth-factor shedding into the extracellular space. Nature. 2004;429(6987):83-86.
78. Simon MC, Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol. 2008;9(4):285-296.
79. Dang SM, Gerecht-Nir S, Chen J, Itskovitz-Eldor J, Zandstra PW. Controlled, scalable embryonic stem cell differentiation culture. Stem Cells. 2004;22(3):275-282.
80. Purpura KA, George SH, Dang SM, Choi K, Nagy A, Zandstra PW. Soluble FLt-1 regulates Flk-1 activation to control hematopoietic and endothelial development in an oxygen responsive manner. Stem Cells. 2008;26(11):2832-2842.
81. Hosokawa K, et al. Function of oxidative stress in the regulation of hematopoietic stem cell-niche interaction. Biochem Biophys Res Commun. 2007;363(3):578-583.
82. Park J, Bansal T, Pinelis M, Maharbiz MM. A microsystem for sensing and patterning oxidative microgradients during cell culture. Lab Chip. 2006;6(5):611-622.
83. Chaudhry MA, Vitalis TZ, Bowen BD, Piret JM. Basal medium composition and serum or serum replacement concentration influences on the maintenance of murine embryonic stem cells. Cytotechnology. 2008;58(3):173-179.
84. Krommenhoek EE, et al. Lab-scale fermentation tests of microchip with integrated electrochemical sensors for pH, temperature, dissolved oxygen and viable biomass concentration. Biotechnol Bioeng. 2008;99(4):884-892.
85. Papin JA, Hunter T, Palsson BO, Subramaniam S. Reconstruction of cellular signalling networks and analysis of their properties. Nat Rev Mol Cell Biol. 2005;6(2):99-111.
86. Han M, Gao X, Su JZ, Nie S. Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol. 2001;19(7):631-635.
87. Peerani R, Onishi K, Mahdavi A, Kumacheva E, Zandstra PW. Manipulation of signaling thresholds in "engineered stem cell niches" identifies design criteria for pluripotent stem cell screens. PLoS One. 2009;4(7):e6438.
88. Roeder I, Braesel K, Lorenz R, Loeffler M. Stem cell fate analysis revisited: interpretation of individual clone dynamics in the light of a new paradigm of stem cell organization. J Biomed Biotechnol. 2007;2007(3):84656.
89. Madlambayan GJ, et al. Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. Exp Hematol. 2005;33(10):1229-1239.
90. Chen X, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell. 2008;133(6):1106-1117.
91. Bao S, et al. Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature. 2009;461(7268):1292-1295.
92. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005;23(1):47-55.
93. Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol. 2006; 7(3):211-224.
94. Hung PJ, Lee PJ, Sabounchi P, Lin R, Lee LP. Continuous perfusion microfluidic cell culture array for high-throughput cell-based assays. Biotechnol Bioeng. 2005;89(1):1-8.
95. DeForest CA, Polizzotti BD, Anseth KS. Sequential click reactions for synthesizing and patterning three-dimensional cell microenvironments. Nat Mater. 2009;8(8):659-664.
96. Kloxin AM, Kasko AM, Salinas CN, Anseth KS. Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science. 2009;324(5923):59-63.
97. Arai F, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118(2):149-161.
98. Matrosova VY, Orlovskaya IA, Serobyan N, Khaldoyanidi SK. Hyaluronic acid facilitates the recovery of hematopoiesis following 5-fluorouracil administration. Stem Cells. 2004;22(4):544-555.
99. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006;12(10):1167-1174.
100. Krause DS, Lazarides K, von Andrian UH, Van Etten RA. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med. 2006;12(10):1175-1180.
101. Matsunaga T, et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med. 2003;9(9):1158-1165.
102. Liesveld JL, et al. Acute myelogenous leukemia - microenvironment interactions: role of endothelial cells and proteasome inhibition. Hematology. 2005; 10(6):483-494.
103. Nervi B, et al. Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood. 2009;113(24):6206-6214.
104. Kaplan RN, Rafii S, Lyden D. Preparing the "soil": the premetastatic niche. Cancer Res. 2006; 66(23):11089-11093.
105. Kaplan RN, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438(7069):820-827.
106. Hiratsuka S, Watanabe A, Aburatani H, Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol. 2006; 8(12):1369-1375.
107. LaBarge MA, et al. Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments. Integr Biol. 2009;1:70-79.
108. LaBarge MA, Petersen OW, Bissell MJ. Of microenvironments and mammary stem cells. Stem Cell Rev. 2007;3(2):137-146.
109. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2002; 99(7):4391-4396.
110. Ungrin MD, Joshi C, Nica A, Bauwens C, Zandstra PW. Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One. 2008;3(2):e1565.
111. Lee LH, Peerani R, Ungrin M, Joshi C, Kumacheva E, Zandstra P. Micropatterning of human embryonic stem cells dissects the mesoderm and endoderm lineages. Stem Cell Res. 2009;2(2):155-162.
112. Fok EY, Zandstra PW. Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation. Stem Cells. 2005; 23(9):1333-1342.
113. Bauwens C, Yin T, Dang S, Peerani R, Zandstra PW. Development of a perfusion fed bioreactor for embryonic stem cell-derived cardiomyocyte generation: oxygen-mediated enhancement of cardiomyocyte output. Biotechnol Bioeng. 2005; 90(4):452-461.
114. Purpura KA, George SH, Dang SM, Choi K, Nagy A, Zandstra PW. Soluble Flt-1 regulates Flk-1 activation to control hematopoietic and endothelial development in an oxygen-responsive manner. Stem Cells. 2008;26(11):2832-2842.
115. Yu TT, Shoichet MS. Guided cell adhesion and outgrowth in peptide-modified channels for neural tissue engineering. Biomaterials. 2005; 26(13):1507-1514.
116. Silva EA, Kim ES, Kong HJ, Mooney DJ. Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A. 2008;105(38):14347-14352.
117. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006; 25(6):977-988.
118. Bhardwaj G, et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol. 2001; 2(2):172-180.
119. Kollet O, et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med. 2006;12(6):657-664.
120. Fleming HE, et al. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell. 2008;2(3):274-283.
121. Kopp HG, Avecilla ST, Hooper AT, Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda). 2005;20:349-356.
122. Adams GB, et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature. 2006;439(7076):599- 603.
123. Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood. 2004;103(5):1580-1585.
124. Nilsson SK, et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood. 2005;106(4):1232-1239.
125. Craddock CF, Nakamoto B, Andrews RG, Priestley GV, Papayannopoulou T. Antibodies to VLA4 integrin mobilize long-term repopulating cells and augment cytokine-induced mobilization in primates and mice. Blood. 1997;90(12):4779-4788.
126. Pruijt JF, van Kooyk Y, Figdor CG, Lindley IJ, Willemze R, Fibbe WE. Anti-LFA-1 blocking antibodies prevent mobilization of hematopoietic progenitor cells induced by interleukin-8. Blood. 1998;91(11):4099-4105.
127. Jung Y, et al. Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. Blood. 2007;110(1):82-90.
128. Weber JM, Calvi LM. Notch signaling and the bone marrow hematopoietic stem cell niche [published online ahead of print August 11, 2009]. Bone. doi:10.1016/j.bone.2009.08.007.
129. Kurth I, Franke K, Pompe T, Bornhauser M, Werner C. Hematopoietic stem and progenitor cells in adhesive microcavities. Integr Biol. 2009;1:427-434.
130. Walker MR, Patel KK, Stappenbeck TS. The stem cell niche. J Pathol. 2009;217(2):169-180.
131. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS. Haematopoietic stem cell release is regulated by circadian oscillations. Nature. 2008;452(7186):442-447.